You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatocellular Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Cancer Trial in San Antonio (Sorafenib (SOR), Hydroxychloroquine (HCQ))

Recruiting
  • Hepatocellular Cancer
  • Sorafenib (SOR)
  • Hydroxychloroquine (HCQ)
  • San Antonio, Texas
    University of Texas Health Cancer Center
Sep 16, 2022

Carcinoma, Hepatocellular, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Seoul (Microwave ablation)

Active, not recruiting
Has Results
  • Carcinoma, Hepatocellular
  • +3 more
  • Microwave ablation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 23, 2023

d To Treat People With Hepatocellular Carcinoma

Recruiting
  • Hepatocellular Cancer
  • Tokyo, Japan
    Takeda Selected Site
Dec 5, 2022

Hepatocellular Cancer Trial in Shanghai (Anlotinib;Toripalimab)

Recruiting
  • Hepatocellular Cancer
  • Shanghai, Shanghai, China
    Eastern hepatobilliary surgery hospital
Jul 7, 2022

Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatocellular Carcinoma Non-resectable Trial in Seoul (Atezolizumab plus

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab plus bevacizumab, combined EBRT to vascular invasion
  • Atezolizumab plus bevacizumab
  • Seoul, Korea, Republic of
    Asan Medical Center
Aug 7, 2023

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Pancreatic Cancer Trial run by the NCI (nivolumab, tadalafil, oral

Completed
  • Hepatocellular Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Hepatocellular Cancer Trial in Clichy (IRM with a 5-minute- additional sequence to measure FRM)

Completed
  • Hepatocellular Cancer
  • IRM with a 5-minute- additional sequence to measure FRM
  • Clichy, France
    Valérie Vilgrain
Jun 20, 2022

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Hepatocellular Carcinoma Trial run by the NCI (Cyclophosphamide,

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Boston (Durvalumab, Tremelimumab,

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 18, 2023

Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial run by the NCI (durvalumab,

Recruiting
  • Hepatocellular Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Vascular Invasion Signatures in cfDNA Support Re-staging of

Completed
  • Carcinoma, Hepatocellular
  • +2 more
  • Liver resection
  • Shanghai, Shanghai, China
    Eastern Hepatobiliary Surgery Hospital, Naval Medical University
Sep 15, 2022

Carcinoma, Hepatocellular, Hepatic Carcinoma, Hepatocellular Cancer Trial in Hannover (Nivolumab, TACE)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • +2 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Nov 21, 2022

Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer Trial in Edmonton (Durvalumab, Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Durvalumab
  • +5 more
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Feb 1, 2023

Liver Tumors Trial in Zhongshan (Biomarker testing and Ultrasonography)

Active, not recruiting
  • Liver Neoplasms
  • Biomarker testing and Ultrasonography
  • Zhongshan, Guangdong, China
    Zhongshan People's Hospital
Apr 23, 2022

Hepatocellular Cancer, Microwave Ablation, Microwave Thermosphere Ablation Trial (True circular microwave needle)

Recruiting
  • Hepatocellular Cancer
  • +3 more
  • True circular microwave needle
  • Tianjin, Tianjin, China
    Tianjin Third Central Hospital
Dec 11, 2022

Carcinoma, Hepatocellular Trial in Navi Mumbai (radiation, procedure, drug)

Recruiting
  • Carcinoma, Hepatocellular
  • SBRT
  • +2 more
  • Navi Mumbai, Maharashtra, India
  • +1 more
Apr 25, 2022

Hepatocellular Carcinoma, Solid Tumor, Hepatocellular Carcinoma Non-resectable Trial in San Antonio (OTX-2002, Tyrosine kinase

Not yet recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • San Antonio, Texas
    Next Oncology
Aug 9, 2022

Recurrent Hepatocellular Cancer, Chronic Liver Disease and Cirrhosis Trial in Seoul (Radiofrequency ablation using combined

Recruiting
  • Recurrent Hepatocellular Cancer
  • Chronic Liver Disease and Cirrhosis
  • Radiofrequency ablation using combined bipolar and monopolar energy deliver with Triple Cooled-Wet electrodes
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 10, 2022

Hepatocellular Cancer Trial in Phoenix, Chicago, Winston-Salem (device, drug, other)

Recruiting
  • Hepatocellular Cancer
  • TheraBionic Device
  • +2 more
  • Tampa, Florida
  • +6 more
Dec 12, 2022

Stage III Hepatocellular Cancer (CNLC Staging) Trial in Guangzhou (mFOLFOX7+Camrelizumab+Apatinib)

Recruiting
  • Stage III Hepatocellular Cancer (CNLC Staging)
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Jun 6, 2022

Hepatocellular Cancer, Liver Cirrhoses, Diagnoses Disease Trial in Tianjin (Diagnostic Sonazoid-CEUS and EOB-MRI)

Recruiting
  • Hepatocellular Cancer
  • +2 more
  • Diagnostic Sonazoid-CEUS and EOB-MRI
  • Tianjin, Tianjin, China
    Tianjin Third Central Hospital
Dec 11, 2022

Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer Trial (Q702, Pembrolizumab)

Not yet recruiting
  • Esophageal Cancer
  • +3 more
  • (no location specified)
Jun 27, 2022

Blood, Urine, and Bone Marrow

Recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • Test for circulating tumor cells, DNA alterations
  • Columbia, Missouri
    Harry S Truman Veterans Memorial Hospital
Oct 31, 2022

Recurrent Hepatocellular Carcinoma, Refractory Liver Carcinoma, Stage IV Hepatocellular Carcinoma AJCC v8 Trial in Scottsdale,

Active, not recruiting
  • Recurrent Hepatocellular Carcinoma
  • +4 more
  • Scottsdale, Arizona
  • +2 more
Oct 7, 2022

Recurrent Hepatocellular Cancer Trial (toripalimab, Lenvatinib, Radiofrequency ablation)

Not yet recruiting
  • Recurrent Hepatocellular Cancer
  • (no location specified)
Jan 12, 2022